Get the latest news on Bioporto stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on THOXF performance

Latest Bioporto Stock News | OTC:THOXF | Benzinga

Bioporto AS is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's products include the NGAL Test, ELISA kits, Antibodies, and Other products and licenses. Geographically, it derives a majority of its revenue from North America.

Comments

Bioporto Stock News

News

Latest Bioporto Stock News | OTC:THOXF | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga